Toseina 250ml fosfato de codeina
Toseina 250ml fosfato de codeina is an antitussive agent that relieves coughing by inhibiting the cough center. Therapeutic indications Toseina lean is indicated for the symptomatic treatment of non-productive irritative cough.
Codeine administration may obscure the diagnosis or clinical course of patients with acute abdominal conditions. Like other narcotics, it causes adverse reactions that can obscure the clinical course of patients with head injuries. Physical dependence and tolerance may develop with repeated administration of this drug. Administration should be gradually discontinued after prolonged treatment.
Dosage Toseina 250ml
Do not take Toseina 250ml : – If you are allergic to codeine or any of the other ingredients of this medicine – If you are under 12 years of age. – If you know that you metabolize codeine very quickly to morphine. – If you are breast-feeding. – It should not be used in case of chronic obstructive pulmonary disease, respiratory depression and acute asthma attacks.
It should not be used in diarrhea associated with pseudomembranous colitis, caused by cephalosporins, lincomycins, or penicillins, or in diarrhea caused by intoxication until all toxic material has been eliminated from the gastrointestinal tract. – It should not be administered in case of a history of drug abuse and hypersensitivity to other opiate derivatives, due to the possibility of serious recurrences. Adolescents over 12 years of age Codeine not recommended adolescents compromised respiratory function for the treatment of cough.
What Toseina lean contains The active substance is codeine phosphate (hemihydrate) – 10 mg/5 ml The other ingredients are sodium benzoate, sorbitol, aspartame, citric acid monohydrate, hydroxyethyl cellulose, sodium saccharin, contramarum flavor, essence raspberry, azorubine, purified water What Tosein looks like and contents of the pack Oral solution. 250 ml bottle with measuring cup.
Marketing Authorization Holder and Manufacturer Marketing Authorization Holder ITF Healthvita, Produtos Farmacêuticos, Lda. Rua Consiglieri Pedroso, nº 123 2730-056 Barcarena Portugal Manufacturer Italfarmaco, SA C/ San Rafael, 3 – 28108 Alcobendas Madrid Spain This brochure was last revised on
Keep Toseina lean out of the sight and reach of children. Do not store above 25ºC. This medicine should be kept in a cool, dry place, protected from light. Do not use this medicine after the expiry date which is stated on the pack. The expiry date corresponds to the last day of the indicated month. Do not dispose of any medicines down the drain or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Side effects Toseina 250ml
Like all medicines, Toseina 250ml can cause side effects, although not everybody gets them. The undesirable effects of codeine are comparable to those of other opiates, but at therapeutic doses they are rarer and milder. The most common adverse reactions characteristic of the opioid class are dizziness, sedation, nausea and vomiting and sweating.
In addition to these, the following can happen: euphoria, dysphoria, confusional states, insomnia, agitation, fear, hallucinations, drowsiness, mood change, headache, vision changes. In terms of the digestive tract, abdominal pain, taste changes, dry mouth, loss of appetite and constipation are referred. From the cardiovascular system: collapse of peripheral circulation, tachycardia, bradycardia, arrhythmias, hypertension, orthostatic hypotension. In the genitourinary system: sphincter spasms, urinary retention, oliguria, antidiuretic effect.
There are also hypersensitivity reactions, pruritus, urticaria, laryngospasm. Possible bronchospasm, changes in temperature regulation, muscle stiffness and paresthesia may also be mentioned. Reporting side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to INFARMED IP through the contacts below.